Table 2.
Patient clinicopathological characteristics
| Clinicopathological characteristics | LNM (n=44) | Non-LNM (n=56) | P value |
|---|---|---|---|
| Sex | 0.650 | ||
| Male | 12 (27.3%) | 13 (23.2%) | |
| Female | 32 (72.7%) | 43 (76.8%) | |
| Age (mean±SD) | 45.90±11.52 | 47.24±12.16 | 0.688 |
| <45y | 20 (45.5%) | 23 (41.1%) | |
| ≥45y | 24 (54.5%) | 33 (58.9%) | |
| Multifocality | 0.179 | ||
| Unifocal | 29 (65.9%) | 44 (78.6%) | |
| Multifocal | 15 (34.1%) | 12 (21.4%) | |
| Tumor (T) | 0.000 | ||
| T1a | 20 (45.5%) | 47 (83.9%) | |
| T1b | 24 (54.5%) | 9 (16.1%) | |
| Lymph node (N) | / | ||
| N0 | 0 (0.0%) | 56 (100.0%) | |
| N1a | 28 (63.6%) | 0 (0.0%) | |
| N1b | 16 (36.4%) | 0 (0.0%) | |
| Metastasis (M) | |||
| M0 | 44 (100%) | 56 (100%) | 1.000 |
| pTNM stage | |||
| Early (I/II) | 20 (45.5%) | 56 (100.0%) | 0.000 |
| Advanced (III/IV) | 24 (54.5%) | 0 (0.0%) |